At least one VIE exists in the corporate structure
Yantai Bohai Pharmaceuticals Group Co., Ltd. went public via a share exchange on January 5, with Link Resources.
Based in the city of Yantai, Shandong Province, China, Bohai is a profitable company principally engaged in the production, manufacturing and distribution of herbal pharmaceuticals based on traditional Chinese medicine in China. Bohai’s medicines address common health problems such as rheumatism, rheumatoid arthritis, respiratory diseases, viral infections, gynecological diseases and cardio vascular issues. Bohai’s products are sold either by prescription through hospitals or Over the Counter through local pharmacies and retail drug store chains. Sales and distribution are managed and executed by about 260 sales representatives located in 20 offices throughout China as of November 2009. In a significant development, on December 1, 2009, two of Bohai’s lead products, Tongbi Capsules and Tablets and Lung Nourishing Cream, became eligible for reimbursement under China’s National Medical Insurance Program.
Reverse Merger Filing
Web site: http://bohaipharma.com/
Last updated January 12, 2010
You are attempting to access a page that requires a full Platinum Membership. Because you currently have access to and receive our Premium Alerts, we believe the ability to read why we issue our alerts is invaluable.
Our alerts reference every facet of our research:
- Premium emails
- RFT's (Reasons for Tracking)
- In-depth due diligence reports
- Spotlight research updates
- Positions Screens & Mock Portfolios
Because you have already subscribed to our Premium Alert service, we are happy to extend to you an upgrade at a very steep discount.
Just use code code TWEETUP12 to receive an 80% discount off our Annual Platinum plan, which blows away the current 60% discount we regularly offer.
And even better yet, you get one week to decide if it's right for you.
Upgrade Now and Join Thousands Who Read Our Research Every Day